MUTATED REP ENCODING SEQUENCES FOR USE IN AAV PRODUCTION
    6.
    发明申请
    MUTATED REP ENCODING SEQUENCES FOR USE IN AAV PRODUCTION 有权
    用于AAV生产的MUTATED REP编码序列

    公开(公告)号:US20130023034A1

    公开(公告)日:2013-01-24

    申请号:US13583920

    申请日:2011-03-11

    摘要: The invention relates to a nucleic acid comprising a nucleotide sequence encoding a Parvoviral Rep protein, wherein a nuclear localization signal (NLS) in said Parvoviral Rep protein is mutated as compared with a corresponding wild type sequence. The invention also relates to a nucleic acid comprising a nucleotide sequence encoding a Parvoviral Rep protein, wherein the zinc finger domain in said Parvoviral Rep protein is mutated as compared with a corresponding wild type sequence. Further, the invention relates to a nucleic acid comprising a nucleotide sequence encoding a Parvoviral Rep protein, wherein an amino acid at position 43, 57, 79, 97, 120, 179, 305, 484, 493 or 571 of the said Parvoviral Rep protein is mutated in comparison to a corresponding wild type sequence, said amino acid position being defined with reference to SEQ ID NO: 2.

    摘要翻译: 本发明涉及包含编码细小病毒Rep蛋白的核苷酸序列的核酸,其中所述细小病毒Rep蛋白中的核定位信号(NLS)与相应的野生型序列相比是突变的。 本发明还涉及包含编码细小病毒Rep蛋白的核苷酸序列的核酸,其中所述细小病毒Rep蛋白中的锌指结构域与相应的野生型序列相比是突变的。 此外,本发明涉及包含编码细小病毒Rep蛋白的核苷酸序列的核酸,其中所述细小病毒Rep蛋白的43,57,79,97,120,179,305,484,493或571位的氨基酸 与相应的野生型序列相比突变,所述氨基酸位置参照SEQ ID NO:2定义。